Table 4: TGFβ level, sCD30 level, and complement activation before, during, and after hemodialysis.

Before dialysisAfter one hour of dialysisAt the end of dialysis15 minutes after end of dialysisReference range

TGFβ (ng/ml)
Median (min–max)23.71 (14.4-44.34)13.47 (6.38-22.92)20.58 (16.19-23.25)20.68 (13.24-27.89)18.3-63.4
sCD30 (ng/ml)
Median (min–max)80.1 (45.05-205.88)84.45 (38.18-212.96)88.67 (41.75-212.47)85.96 (55.2-232.18)7.7-60.5
Classical pathway (%)
Median (min–max)106.4 (86.7-124.8)101.7 (80.6-115)104.4 (80.8-114.6)103.9 (85.5-118.5)69-129
Alternative pathway (%)
Median (min–max)86.7 (54.4-115)84.5 (49.8-98.4)78.2 (41.8-94.8)87.9 (63.9-104.8)30-113

Mentioned in the manufacturer’s instructions (Human TGF-β1 Quantikine ELISA, R&D Systems; Human sCD30 ELISA, BioVendor; Wieslab COMPL CP310, Euro-Diagnostica; Wieslab COMPL AP 330, Euro-Diagnostica). min: minimum; max: maximum. Statistical analysis with nonparametric tests are shown in Table 3.